Table 1.
IC50 Afatinib 72 h (μM) | |||
---|---|---|---|
Cell Line | Cetuximab Resistance Status | Normoxia (21% O2) |
Hypoxia (1% O2) |
Lim1215 | Sensitive | 0.081 ± 0.021 | 0.178 ± 0.055 |
CaCo2 | Sensitive | 0.341 ± 0.199 | 0.604 ± 0.307 |
SW48 | Intrinsically resistant | 2.379 ± 0.869 | 2.109 ± 0.691 |
HT29 | Intrinsically resistant | 1.805 ± 0.041 | 1.816 ± 0.117 |
Lim1215-PBS | PBS-treated control, sensitive | 0.007 ± 0.002 | 0.010 ± 0.003 |
Lim1215-R | Acquired resistance | 0.174 ± 0.030 | 0.458 ± 0.060 |
CaCo2-PBS | PBS-treated control, sensitive | 0.591 ± 0.384 | 0.260 ± 0.197 |
CaCo2-R | Acquired resistance | 1.570 ± 0.264 | 1.398 ± 0.270 |